Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes.
| Website: | www.transitiontherapeutics.com |
| Email: | info@transitiontherapeutics.com |
| Main Phone: | +1 416 260-7770 |
| Address: | 101 College Street |
| Address 2: | Suite 220 |
| State: | ON |
| City / Town: | Toronto |
| Country: | CAN |
| Postal Code: | M5G 1L7 |
| Exchange: | TSX |
| CEO: | Tony F. Cruz |
| Employees: | 18 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume 0 | 52 Wk Hi 3.54 | 52 Wk Low 0.89 |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 38,798,971.00 | EPS (TTM) -0.65 | PE Ratio N/A | Exchange TSX |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 5.5 | 5.5 | 5.5 | 5.5 |
| Low Target Price Estimate | 5.5 | 5.5 | 5.5 | 5.5 |
| Mean Target Price Estimate | 5.5 | 5.5 | 5.5 | 5.5 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 04/29/14 | 04/29/14 | 04/29/14 | 04/29/14 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 3 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
